Comparison of Symptom Control in Pediatric Gastroparesis Using Endoscopic Pyloric Botulinum Toxin Injection and Dilatation.


Journal

Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545

Informations de publication

Date de publication:
01 09 2021
Historique:
pubmed: 7 6 2021
medline: 25 2 2023
entrez: 6 6 2021
Statut: ppublish

Résumé

The objective of this study was to assess the tolerance and efficacy of endoscopic intrapyloric botulinum toxin injection compared with pyloric dilatation in children with gastroparesis. This was a retrospective descriptive multicentre study that included pediatric patients treated between 2010 and 2018 at 4 tertiary hospitals. Data were collected for 24 patients. The median age at diagnosis was 2.5 years (range 0.5-4.7). A total of 46 endoscopic procedures were performed. The endoscopic procedure was multiple in 63% of patients. Among the interventions, 76% were successful and 15% were unsuccessful. The recurrence rate was 57% and the median time to recurrence was 3.7 months (0.1-73). The efficacy did not differ significantly between the 2 methods at the first intervention and as a second-line treatment. The recurrence rate also did not differ significantly between the 2 methods. No complications were reported. The median follow-up was 19.8 months (1.7-61.7). In this retrospective multicentre study, endoscopic management of gastroparesis by balloon dilatation or botulinum toxin was safe in children and seemed to be partially efficient within the first months. Symptoms recurred frequently and required repetition of the interventions.

Identifiants

pubmed: 34091544
doi: 10.1097/MPG.0000000000003195
pii: 00005176-202109000-00006
doi:

Substances chimiques

Botulinum Toxins, Type A EC 3.4.24.69

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

314-318

Informations de copyright

Copyright © 2021 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

Saliakellis E, Fotoulaki M. Gastroparesis in children. Ann Gastroenterol 2013; 26:204–211.
Waseem S, Islam S, Kahn G, et al. Spectrum of gastroparesis in children. J Pediatr Gastroenterol Nutr 2012; 55:166–172.
Edwards ST, Cocjin J, Theut SB, et al. A comparison of the diagnosis of gastroparesis in 4 h pediatric gastric emptying studies versus 2 h studies. BMC Gastroenterol 2019; 19:26.
Leal MC, Oliver MR, Francis P, et al. Gastrointestinal: Botulinum toxin effective in refractory gastroparesis in paediatric practice. J Gastroenterol Hepatol 2015; 30:232–1232.
Chao H-C. Update on endoscopic management of gastric outlet obstruction in children. World J Gastrointest Endosc 2016; 8:635–645.
Kozlov Y, Kovalkov K, Smirnov A. Gastric peroral endoscopic myotomy for treatment of congenital pyloric stenosis-first clinical experience. J Laparoendosc Adv Surg Tech A 2019; 29:860–864.
Islam S. Gastroparesis in children. Curr Opin Pediatr 2015; 27:377–382.
Claudot F, Alla F, Fresson J, et al. Ethics and observational studies in medical research: various rules in a common framework. Int J Epidemiol 2009; 38:1104–1108.
Israel DM, Mahdi G, Hassall E. Pyloric balloon dilation for delayed gastric emptying in children. Can J Gastroenterol 2001; 15:723–727.
Rodriguez L, Rosen R, Manfredi M, et al. Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study. Gastrointest Endosc 2012; 75:302–309.
Rodriguez L, Irani K, Jiang H, et al. Clinical presentation, response to therapy, and outcome of gastroparesis in children. J Pediatr Gastroenterol Nutr 2012; 55:185–190.
Coleski R, Anderson MA, Hasler WL. Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients. Dig Dis Sci 2009; 54:2634–2642.
Arts J, Holvoet L, Caenepeel P, et al. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 2007; 26:1251–1258.
Friedenberg FK, Palit A, Parkman HP, et al. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 2008; 103:416–423.
Thomas A, de Souza Ribeiro B, Malespin M, et al. Botulinum toxin as a treatment for refractory gastroparesis: a literature review. Curr Treat Options Gastroenterol 2018; 16:479–488.
Bai Y, Xu M-J, Yang X, et al. A systematic review on intrapyloric botulinum toxin injection for gastroparesis. Digestion 2010; 81:27–34.
Weusten BLAM, Barret M, Bredenoord AJ, et al. Correction: endoscopic management of gastrointestinal motility disorders - part 1: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2020; 52:C6.
Pasricha TS, Pasricha PJ. Botulinum toxin injection for treatment of gastroparesis. Gastrointest Endosc Clin N Am 2019; 29:97–106.
Hirsch S, Nurko S, Mitchell P, et al. Botulinum Toxin as a Treatment for Feeding Difficulties in Young Children. J Pediatr 2020; S0022-3476(20)30766-6.
Heymans HS, Bartelsman JW, Herweijer TJ. Endoscopic balloon dilatation as treatment of gastric outlet obstruction in infancy and childhood. J Pediatr Surg 1988; 23:139–140.
Chan KL, Saing H. Balloon catheter dilatation of peptic pyloric stenosis in children. J Pediatr Gastroenterol Nutr 1994; 18:465–468.
Treem WR, Long WR, Friedman D, et al. Successful management of an acquired gastric outlet obstruction with endoscopy guided balloon dilatation. J Pediatr Gastroenterol Nutr 1987; 6:992–996.
Jawaid W, Abdalwahab A, Blair G, et al. Outcomes of pyloroplasty and pyloric dilatation in children diagnosed with nonobstructive delayed gastric emptying. J Pediatr Surg 2006; 41:2059–2061.
Setya A, Nair P, Cheng SX. Gastric electrical stimulation: an emerging therapy for children with intractable gastroparesis. World J Gastroenterol 2019; 25:6880–6889.
Khashab MA, Stein E, Clarke JO, et al. Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video). Gastrointest Endosc 2013; 78:764–768.
Gonzalez J-M, Lestelle V, Benezech A, et al. Gastric per-oral endoscopic myotomy with antropyloromyotomy in the treatment of refractory gastroparesis: clinical experience with follow-up and scintigraphic evaluation (with video). Gastrointest Endosc 2017; 85:132–139.
Lee Y, Brar K, Doumouras AG, et al. Peroral endoscopic myotomy (POEM) for the treatment of pediatric achalasia: a systematic review and meta-analysis. Surg Endosc 2019; 33:1710–1720.

Auteurs

Clémence Mercier (C)

Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University Lille, Inserm, U1286 - Infinite, CHU Lille, Lille.

Delphine Ley (D)

Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University Lille, Inserm, U1286 - Infinite, CHU Lille, Lille.

Madeleine Aumar (M)

Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University Lille, Inserm, U1286 - Infinite, CHU Lille, Lille.

Julie Lemale (J)

Department of Pediatric Nutrition and Gastroenterology, Trousseau Hospital-APHP, Sorbonne University, Paris.

Alexandre Fabre (A)

APHM, Timone Enfant, Service de pédiatrie multidisciplinaire, AP-HM, Marseille, France Aix Marseille Univ, INSERM, MMG, Marseille.

Stéphanie Colinet (S)

Gastroentérologie pédiatrique, Montlégia Hospital, CHC, Liège, Belgique.

Alain Duhamel (A)

Unité de Méthodologie, Biostatistique et Data Management, CHU de Lille, France.

Frédéric Gottrand (F)

Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University Lille, Inserm, U1286 - Infinite, CHU Lille, Lille.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH